A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell Lymphoma
Alisertib 加 Ibrutinib 加 Rituximab 的新型三联疗法对套细胞淋巴瘤有效
期刊:Cancers
影响因子:
doi:10.3390/cancers16244257
Baskaran Subramani, Patrick J Conway, Aisha Al-Khinji, Kun Zhang, Ritu Pandey, Daruka Mahadevan
